Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
|
CN |
|
Bioceres Crop Solutions Corp
NASDAQ:BIOX
|
AR |
|
Open House Group Co Ltd
OTC:OPPPF
|
JP |
|
C
|
China International Capital Corp Ltd
F:CIM
|
CN |
Intrinsic Value
Is Chengdu Easton Biopharmaceuticals Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Chengdu Easton Biopharmaceuticals Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Chengdu Easton Biopharmaceuticals Does
Chengdu Easton Biopharmaceuticals makes and sells biologic drugs, with a focus on recombinant protein medicines. These are medicines made by engineered cells rather than by simple chemical synthesis, and they are used in areas such as hospital treatment and specialty care. The company also works on the development and manufacturing steps needed to turn those proteins into approved prescription products.
- Headquarters
- China CN
- Employees
- 1 480
- IPO date
- Sep 2, 2020
Earnings Waterfall
Chengdu Easton Biopharmaceuticals Co Ltd
The intrinsic value for Chengdu Easton Biopharmaceuticals Co Ltd (688513) under the Base Case is hidden CNY.
Compared with the current market price of 40.68 CNY, the stock appears hidden.
